As an attending physician in the Lymphoma Division and director of the T-Cell Lymphoma Program at John Theurer Cancer Center, I am optimistic that current research into intercellular mechanisms can generate effective new therapies for treating this rare type of lymphoma. Immunotherapy, specifically CAR-T 19 cells that are genetically modified to attack lymphoma cells, is an especially exciting new approach.
Catherine Thieblemont, Tycel Phillips, Herve Ghesquieres, Chan Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojc...> ;Journal of Clinical Oncology. 2023 Apr 20
Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricard...> ;The Lancet. Haematology. 2023 Jan 1
Alexandra Della Pia, Charles Zhao, Parul Jandir, Amolika Gupta, Mark Batistick, Gee Youn Geeny Kim, Yi Xia, Jaeil Ahn, Gabriella Magarelli, Brittany Lukasik, Lori A Le...> ;Cancers. 2022 Aug 31
Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, Seongho Kim, Krish Patel, Nancy L Bartlett, Mary-Kate Malecek, Marcus P Watkins, Kami J Maddocks, David A Bond,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
Alexandra Della Pia, Gee Youn Geeny Kim, Andrew Ip, Jaeil Ahn, Yanzhi Liu, Simone Kats, Michael Koropsak, Brittany Lukasik, Anamta Contractor, Krushna Amin, Lakshmi Ay...> ;Plos One. 2022 Jan 1
Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees, Natalie S Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T...> ;Blood Advances. 2021 Sep 28
Ranjana H. Advani, Alison J. Moskowitz, Nancy L. Bartlett, Julie M. Vose, Radhakrishnan Ramchandren, Tatyana Feldman, Ann S. LaCasce, Beth A. Christian, Stephen M. Ans...> ;Blood. 2021 Aug 12
Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim...> ;Blood Advances. 2021 Jul 27
Andrew M. Evens, Joseph M. Connors, Anas Younes, Stephen M. Ansell, Won Seog Kim, John Radford, Tatyana Feldman, Joseph Tuscano, Kerry J. Savage, Yasuhiro Oki, Andrew ...> ;Haematologica. 2021 Jun 24
David J. Straus, Monika Długosz-Danecka, Joseph M. Connors, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Marańda, Tatyana Feldman, Piotr Smolewski, Kerry J. S...> ;The Lancet. Haematology. 2021 Jun 1
Alan P Skarbnik, Michele L. Donato, Rena Feinman, Scott D. Rowley, David H. Vesole, Andre Goy, Pashna N. Munshi, Tatyana Feldman, Lori A. Leslie, Noa Biran, Themba Nyi...> ;Transplantation and Cellular Therapy. 2021 May 1
Michele L. Donato, Steven I. Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, Ming Tan, Andrew Ip, Stuart L. Goldberg, Scott D. Rowley, Kar F. Chow, Em...> ;JCI Insight. 2021 Mar 22
Reid W. Merryman, Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti, Beatrice Casadei, David A. Bond, Samantha Jaglowski, Michael A. Spinner...> ;Leukemia. 2021 Mar 3
Adam J. Olszewski, Lasse Hjort Jakobsen, Graham P. Collins, Kate Cwynarski, Veronika Bachanova, Kristie A. Blum, Kirsten M Boughan, Mark Bower, Alessia Dalla Pria, Ale...> ;Journal of Clinical Oncology. 2021 Jan 27
Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Daniel Rector, Suchitra Sundaram, Nishitha Reddy, Yong Lin, ...> ;Blood. 2021 Jan 21
Bruce D. Cheson, Nancy L. Bartlett, Betsy LaPlant, Hun J Lee, Ranjana J Advani, Beth Christian, Catherine Diefenbach, Tatyana Feldman, Stephen M. Ansell> ;The Lancet. Haematology. 2020 Nov 1
Matthew K. Howe, Kennichi C. Dowdell, Hye Sun Kuehn, Qingxue Li, Geoffrey T. Hart, Doreen Garabedian, Kelly Liepshutz, Amy P. Hsu, Hua Su, Julie E. Niemela, Jennifer S...> ;The Journal of Infectious Diseases. 2020 Sep 1
Tatyana Feldman, Denise Zou, Mayvis Rebeira, Joseph K. T. Lee, Michelle A. Fanale, Thomas Manley, Shangbang Rao, Joseph Feliciano, Mack Harris, Anuraag Kansal> ;The American Journal of Managed Care. 2020 Feb 1
Frederick Lansigan, Steven M. Horwitz, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro, Eric D. Hsi, Massimo Federico, Christian Gisselbrecht, Marc Schwartz, Lisa...> ;Acta Haematologica. 2020 Jan 1
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Marańda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bar...> ;Blood. 2019 Nov 13
Steven M. Bair, Lauren E. Strelec, Tatyana Feldman, Gulrayz Ahmed, Philippe Armand, Nirav N. Shah, Arun N. Singavi, Nishitha Reddy, Nadia Khan, Charalambos Andreadis, ...> ;The Oncologist. 2019 Jul 1
Radhakrishnan Ramchandren, Eva Domingo-Domenech, Antonio Rueda, Marek Trněný, Tatyana Feldman, Hun Ju Lee, Mariano Provencio, Christian Sillaber, Jonathon B. Cohen, Ke...> ;Journal of Clinical Oncology. 2019 May 21
Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Cost-Effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma.
2019 ASCO Annual Meeting - 6/1/2019
Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Resul...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Aetna Choice POS II Aetna HMO AmeriHealth Direct POS Amerihealth HMO AmeriHealth PPO BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO Empire BCBS PPO GHI PPO Great West PPO Healthfirst New York
Horizon BCBS Direct Access Horizon BCBS HMO Horizon BCBS POS Horizon BCBS PPO Humana ChoiceCare Network PPO Multiplan PHCS PPO Multiplan PPO Oxford Health Freedom Oxford Health Liberty QualCare HMO QualCare PPO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: